期刊文献+

肺癌患者Ⅰ类和Ⅱ类辅助T细胞的变化 被引量:1

Variation of type 1 helper and type 2 helper T cells in lung cancer patients
下载PDF
导出
摘要 研究肺癌患者血浆及外周单个核细胞 (PBMC)诱生IL 2、IL 4水平及患者Ⅰ类和Ⅱ类辅助T细胞 (Th1和Th2 )细胞功能。方法 :用细胞因子诱生及ELISA技术 ,测定 30例肺癌术前患者、12例术后患者血清及外周血单个核细胞诱生的IL 2、IL 4水平 ,以IL 2水平反映Th1细胞功能 ,以IL 4水平代表Th2细胞功能。结果 :肺癌患者血清及PBMC诱生产生IL2水平减低 ,而IL 4水平升高 (P <0 0 5 ) ,PBMC诱生及血清IL 2、IL 4水平在不同分期、不同病理类型肺癌病人间比较无显著差别 (P >0 0 5 ) ,行肺癌根治术后的患者血清及PBMC诱生IL 2水平高于未手术肺癌患者水平 (P <0 0 5 )。结论 :肺癌患者体内Th1和Th2细胞亚群功能失调 ,这可能是肺癌组织在患者体内进行性生长及免疫逃避的机制之一 ;肺癌患者Th1和Th2亚群失调在肺癌不同分期、不同病理类型患者间无显著差别 。 Purpose:To study the function of type 1 helper and type 2 helper T (Th1 and Th2) cells in peripheral blood from lung cancer patients. Methods:By using the ELISA technique, we examined interleukin 2 (IL 2),interleukin 4 (IL 4) levels in serum, the productons of IL 2 and IL 4 with PHA by PBMC in 30 cases of lung cancer and 12 postoperative cases. The levels of IL 2 and IL 4 could evaluate respectively the function of The and Th2 subsets. Results:The results showed that there was a decrease of IL 2 and an increase of IL 4 in the peripheral blood of patients (P<0 05),that is ,there was a disregulation in the function of Th1 and Th2 cells, with an expansion in Th2 cells and a malfunction in Th1 cells. More over, there was no correlation among the clinical stages、histological types (P>0 05) while the malfunction of Th1/Th2 subsets decreased in postoperative patients (P<0 05) Conclusions:The data of the study shows that lung cancer patients have a malfunction in Th1 and Th2 subsets, and this may be partially the mechanism that allows the tumor to progress in the host and escape immune surveillance.
出处 《中国癌症杂志》 CAS CSCD 2000年第4期303-305,共3页 China Oncology
关键词 肺肿瘤 辅助T细胞 细胞因子 PBMC TH1/TH2 lung tumor lung cancer type 1 helper and type 2 helper T cells cytokine
  • 相关文献

参考文献10

  • 1SergiRomagnani.HumanTh1andTh2subset:doubtnomore[J].ImmunolToday,1991,12(8):256-257.
  • 2刘杰,魏海明,田志刚.Th1/Th2漂移与抗肿瘤免疫[J].国外医学(肿瘤学分册),1997,24(3):168-170. 被引量:41
  • 3Asselin-PaturelC,EchchakirH,CarayolY,etal.QuantitiveanalysisofTh1,Th2andTGF-betalcytokineexpressionintumor,TiLandPBLofnon-small-celllungcancerpatients[J].IntJCancer,1998,77(1):7-12.
  • 4HuangM,WangJ,LeeP,etal.Humannon-small-celllungcancercellsexpressatype2cytokinepattern[J].CancerRes,1995,155(10):3847-3853.
  • 5TimR,SubashS.TheexpandinguniverseofTcellsubsets:Th1,Th2andmore[J].ImmunolToday,1996,17(3):138-140.
  • 6MchughS,DeightonF,RifkinI,etal.KineticsandfunctionalimplicationsofTh1andTh2cytokineproductionfollowingactivationofperipheralbloodmononuclearcellsinprimaryculture[J].EurJImmunol,1996,6(8):1260-1266.
  • 7刘杰,田志刚,冯进波,魏海明.人肿瘤细胞中Th2类细胞因子的强势表达[J].中华肿瘤杂志,1998,20(2):105-107. 被引量:50
  • 8刘杰 田志刚 孙纳 等.人肿瘤细胞中Th2类细胞因子的逆转NK抗性变化的研究[J].中国肿瘤生物治疗杂志,1997,4(3):206-208.
  • 9唐建武.白细胞介素-2及其受体与肿瘤基因治疗[J].国外医学(分子生物学分册),1995,17(1):12-16. 被引量:14
  • 10Kikokay-AshiM,KbayashiH,RichardB,etal.ApathogenicroleofTh2cellsandtheircytokineproductsonthepulrnonarymetastasisofmurineB16melanoma[J].JImmunol,1998,160(11):5869-5873.

二级参考文献4

  • 1刘杰,国外医学.肿瘤学分册,1997年,24卷,168页
  • 2Huang M,Cancer Res,1995年,55卷,3847页
  • 3张友会,中国肿瘤生物杂志,1995年,2期,239页
  • 4Riks A. Maas,Hub F. J. Dullens,Willem Otter. Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review[J] 1993,Cancer Immunology Immunotherapy(3):141~148

共引文献98

同被引文献11

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部